NEOGENOME · diagnosis
NeoGenoma
Broad investigation of the nuclear and mitochondrial genome, guided by the clinical picture.
Samples: peripheral blood, Mouth swab, DNA extraído, Líquido amniótico
Deadline: até 20 calendar days
Clinical portfolio
The right test starts with the clinical question.
Organize the search for the objective of the investigation. Scope, methodology, deadline and sample type vary depending on the case — our team can support this choice.
The final indication must consider clinical data, family history and previous tests.
- 01
- Clinical question
- 02
- Required scope
- 03
- Variant classes
- 04
- Deadline and sample
Diagnosis
Rare and hereditary diseases.
From the complete genome to targeted analyses, the choice depends on the complexity of the phenotype, the diagnostic hypotheses and the tests already performed.
Complete genome
Know the test
NeoGenoma
Broad investigation of the nuclear and mitochondrial genome, guided by the clinical picture.
Short + long reads
Know the test
NeoGenoma Omni
Additional readings for difficult regions, available from the beginning or as a second step after NeoGenoma.
Patient + family
Know the test
NeoGenoma Trio
Conjoint analysis to support interpretation of inheritance and novel variants in the patient.
ASD and neurodevelopment
Know the test
NeoGenoma TEA
Complete genome, CNV analysis and dedicated Fragile X testing in a single strategy.
Critical situations
Know the test
NeoGenoma UTI
Rapid genome for critically ill patients with suspected genetic condition.
Coding regions
Know the test
NeoExoma
Whole exome with mitochondrial genome co-capture and clinical interpretation.
Family analysis
Know the test
NeoExoma Trio
Patient and family exomes analyzed together to refine interpretation.
High depth
Know the test
NeoExoma Mosaico
Strategy to investigate variants present in a low proportion in the analyzed sample.
Oncogenetics
Hereditary risk of cancer.
Assessments defined by personal and family history, clinical criteria and the range of variants that need to be investigated.
NeoPainel + Super Panel
A strategy proportional to clinical risk.
Compare the targeted analysis of NeoPainel with the breadth of the Cancer Super Panel and understand which approach best aligns with the case.
Compare optionsIncluded
Follow-up Infinity VUS for reported variants.
Prevention
Risk and care throughout life.
Genetic information that can support preventive monitoring, health choices and individualized medical discussion.
01 · Comprehensive prevention
02 · Longitudinal monitoring
03 · Cardiovascular
See the entire Longevity area
Longevo
Assessment of hereditary predispositions relevant to preventive care.
KnowLongevo Premium
The same content as Longevo, with pre- and post-test consultations and annual clinical reassessment for four years.
KnowCardioRisk
Genetic assessment applied to cardiovascular risk and personalized prevention.
KnowReproduction and neonatology
Genetic information at decisive moments.
Tests for reproductive planning and to expand screening for genetic conditions in the neonatal period.
Precision medicine
Pharmacogenomics applied to neurology.
Genetic information can help doctors understand individual differences in response to medications, always integrated into the clinical picture.
Get to know NeoFarma NeurologiaGenetics as an additional layer of information for therapeutic decision-making.
Expert guidance
Still don't know which test makes sense?
Share the clinical question and the tests already carried out. Our team helps organize the next step.
Published catalog
Canonical information about the tests.
Structured and revised content, also available for search engines and integrations.
NEOGENOME-HYBRID · diagnosis
NeoGenoma Omni
Additional readings for difficult regions, available from the beginning or as a second step after NeoGenoma.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: under confirmation
NEOGENOME-TRIO · diagnosis
NeoGenoma Trio
Conjoint analysis to support interpretation of inheritance and novel variants in the patient.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: under confirmation
NEOGENOME-UTI · diagnosis
NeoGenoma UTI
Rapid genome for critically ill patients with suspected genetic condition.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: até 10 calendar days
NEOEXOME · diagnosis
NeoExoma
Whole exome with mitochondrial genome co-capture and clinical interpretation.
Samples: peripheral blood, Mouth swab, DNA extraído, Líquido amniótico
Deadline: under confirmation
NEOEXOME-TRIO · diagnosis
NeoExoma Trio
Patient and family exomes analyzed together to refine interpretation.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: under confirmation
NEOEXOME-MOSAIC · diagnosis
NeoExoma Mosaico
Strategy to investigate variants present in a low proportion in the analyzed sample.
Samples: peripheral blood, Mouth swab, Biópsia de tecido affected, DNA extraído
Deadline: under confirmation
NEOPREVENT · prevention
Longevo
Assessment of hereditary predispositions relevant to preventive care.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: under confirmation
NEOCHECKUP · prevention
Longevo Premium
The same content as Longevo, with pre- and post-test consultations and annual clinical reassessment for four years.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: até 20 calendar days
CARDIORISK · cardiovascular
CardioRisk
Genetic assessment applied to cardiovascular risk and personalized prevention.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: under confirmation
NEOBEBE · neonatal
Longevo Baby
Complements newborn screening with genetic investigation of selected actionable conditions.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: até 20 calendar days
NEOFARMA · pharmacogenomics
NeoFarma Neurology
Pharmacogenomics applied to neurology and psychiatry medicines.
Samples: peripheral blood, Mouth swab, DNA extraído
Deadline: até 10 calendar days
